# Mach5 Therapeutics, Inc. — Form D/A

Mach5 Therapeutics, Inc. of ATLANTA, GA, a company, filed a Form D amendment with the SEC on 2024-04-17. The offering totals $4.5M, of which $4.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-04-17
- Form: D/A
- Accession: 0002018014-24-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $4.2M
- Remaining: $325K
- Investors: 7
- Date of first sale: 2024-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509501

## Issuer

- Name: Mach5 Therapeutics, Inc.
- CIK: 0002018014
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 650 PONCE DE LEON AVE, ATLANTA, GA, 30308
- Phone: 404-487-8769

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Patrick J Crutcher | Promoter | Atlanta, GA |
| Justin J DiMartino | Promoter | Atlanta, GA |
| Justin J DiMartino | Director | Atlanta, GA |
| Justin J DiMartino | Executive Officer | Atlanta, GA |
| Patrick J Crutcher | Director | Atlanta, GA |
| Patrick J Crutcher | Executive Officer | Atlanta, GA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-11-04](https://search.stillhousedata.com/formd/0001493152-24-043506) | D | $19.9M | $19.2M |
| [2024-04-03](https://search.stillhousedata.com/formd/0002018014-24-000002) | D | $3.0M | $2.7M |

## More

- [CIK 2018014 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2018014&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002018014-24-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.